News » Urgent Care For Children Collaborates With Visby Medical To Provide New Gold Standard Diagnostic For Sexually Transmitted Infections

03/29/2022Press Release

Urgent Care For Children Collaborates With Visby Medical To Provide New Gold Standard Diagnostic For Sexually Transmitted Infections

Pediatric urgent care provider among first in the US to adopt new point-of-care STI diagnostic device in adolescents and young adults

Urgent Care For Children Collaborates With Visby Medical To Provide New Gold Standard Diagnostic For Sexually Transmitted Infections

SAN JOSE, Calif., March 29, 2022 – www.visbymedical.com™, an innovative diagnostic company, today announced its agreement with Urgent Care for Children (UC4C) to offer the company’s new Sexual Health Click Test to patients for the detection of sexually transmitted infections (STIs) in female patients 14 years of age and older. The device can detect chlamydia, gonorrhea, and trichomoniasis, three of the most common and curable STIs, with about 97 percent or greater accuracy. According to the Centers for Disease Control and Prevention, people ages 15 to 24 account for almost half of the 26 million new sexually transmitted infections that occurred in the United States in 2018.

The test offers PCR in palm-sized dimensions and provides accurate results in 28 minutes, with no additional instrument or investment required. Patients provide a vaginal swab self-collected in privacy, and then receive results and proper treatment during the same visit, eliminating typical wait time. The test is being utilized at 11 UC4C locations including Birmingham, Mobile, Vestavia, Trussville, Tuscaloosa, Madison, Huntsville, and Daphne in Alabama; Memphis and Knoxville in Tennessee; and in New Orleans.

Prior to adoption of the Sexual Health Click Test, UC4C clinicians had to wait 24 to 48 hours after specimen collection to receive results, which commonly leads to patients being lost to follow-up. With the Visby device, patients can be tested, counseled, and treated during a single visit, all patients will receive the treatment they need, and none will be lost to follow-up.

“The Sexual Health Click Test is a game-changer because STIs can cause serious complications, and they require communication with patient partners who may or may not be symptomatic who also need to be treated,” said UC4C Founder and Chief Executive Officer Dr. Allury Arora Lal. “With young patients, it’s critical to complete the full cycle from diagnosis to treatment, and to take the additional steps of explaining the entire process to them because we believe that empowering our patients with education and resources is extremely important. Young patients should not be afraid, anxious or nervous to utilize our services for something as confidential as STI testing.”

Knowledge is vital to the prevention and treatment of STIs. With highly accurate results, the Sexual Health Click Test reduces unnecessary over- and under-treatment and accelerates time to receive treatment, therefore decreasing the possibility of transmission and complications due to lack of, or improper, treatment. Immediate results during the patient visit also offer the opportunity to educate patients about STI prevention and risk reduction.

“STI rates are increasing at an alarming rate in the U.S., and there is an urgent need to deliver quick and accurate results directly at the point of care,” said infectious disease expert Gary Schoolnik, MD, chief medical officer at Visby Medical, and Professor of Medicine at Stanford University. “We are proud to support Urgent Care for Children in their efforts to address patients in need with accurate diagnostic results and proper treatment during that single visit.”

About Urgent Care for Children

Urgent Care for Children is a physician-founded pediatric urgent care provider with 20 clinics across the Southeast. UC4C’s licensed, on-site pediatricians and pediatric nurse practitioners offer acute diagnostic and treatment care for children ages zero to 21 with non-life-threatening needs. The company proudly runs the nation’s first sensory-inclusive urgent care facilities. For more information, visit www.childrensurgent.com or visit us on Facebook and Instagram.

About Visby Medical™

Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The Company’s proprietary technology development program culminated in the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. The Visby Medical technology is also helping to fight the global pandemic via the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. Visby Medical is accelerating the delivery of fast and accurate, palm-sized PCR diagnostics to the point of care, and eventually for use at home.

For more information, visit www.visbymedical.com. Follow Visby Medical on LinkedIn; Facebook, and Twitter.
 

Media Contacts:

Urgent Care for Children
Anna Peacock – Vice President, Marketing and Communications
Urgent Care for Children
apeacock@childrensurgent.com
(205) 882-5031

Visby Medical, Inc.
Doug Hochstedler – Vice President, Health
Porter Novelli (on behalf of Visby Medical, Inc.)
doug.hochstedler@porternovelli.com
(317) 645-8665

Read more articles & insights

05/11/2023Viewpoint

Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected

As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May 11, 2023, it is essential to understand how the healthcare industry has adapted and evolved to address the unique challenges posed by the COVID-19 pandemic.

Read More
Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected

03/14/2023Press Release

Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women

Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of care (POC) test.

Read More
Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women

01/03/2023Press Release

Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings

Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.

Read More
Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings

09/15/2022Viewpoint

Visby Tech in the Deep South: How an Alabama Urgent Care is Using Visby

Patients can now get results from PCR tests the same day thanks to new testing choices like Visby.

Read More
Visby Tech in the Deep South: How an Alabama Urgent Care is Using Visby